Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv
- PMID: 2826812
- PMCID: PMC250562
- DOI: 10.1128/JVI.62.2.511-518.1988
Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv
Abstract
Friend virus complex (FV), which comprises replication-competent Friend murine leukemia virus (FMuLV) plus replication-defective spleen focus-forming virus (SFFV), induces a multistage erythroleukemia. We have examined the role of replication-competent helper virus in the early and late stages of FV disease by replacing FMuLV, the native helper, with Akv, the endogenous ecotropic MuLV of AKR mice. SFFVP/FRE, an established fibroblast line nonproductively infected with the polycythemic strain of SFFV, was superinfected with FMuLV or with Akv. Although supernatants from these cells showed similar titers in the XC plaque assay, supernatants from Akv-infected SFFVP/FRE cells showed 100- to 5,000-fold less activity than did those from FMuLV-infected cells with respect to spleen focus induction in vivo. Since virions isolated from these two supernatants contained similar ratios of SFFV to helper virus genomic RNA, it did not appear that the difference was due to a relative inability of Akv to package SFFV. Although FMuLV- and Akv-rescued SFFV are equally infectious in a mouse fibroblast cell line (NIH 3T3), FMuLV-rescued SFFV was far more efficient in inducing erythroid bursts in cultured primary bone marrow cells. Adding Akv to preparations of FMuLV-rescued SFFV did not significantly interfere with burst induction. Helper-free SFFV induced 50- to 500-fold more spleen foci when coinjected with FMuLV than it did with Akv. Helper virus also affected mortality rates that reflect the late stage of the disease. When FMuLV- or Akv-rescued SFFV was injected into NIH Swiss mice at dosage levels adjusted to give equal numbers of spleen foci, all mice receiving FMuLV-rescued SFFV developed splenomegaly and died, whereas no mice receiving Akv-rescued SFFV died or developed detectable splenomegaly. When FMuLV was coinjected with Akv-rescued SFFV, the mortality rate rose from 0 to 100%. Injection of helper-free SFFV alone did not induce mortality, but coinjection of helper-free SFFV with FMuLV resulted in 100% mortality. Thus, the helper virus used to rescue SFFV plays at least a quantitatively important role in the early stage of FV disease and a crucial role in the late stage of the disease in vivo.
Similar articles
-
Sequences present in a small region of the AKV virus envelope gene determine the efficiency with which pseudotyped spleen focus-forming virus infects erythroid target cells.Virology. 1992 Jan;186(1):161-6. doi: 10.1016/0042-6822(92)90070-6. Virology. 1992. PMID: 1309273
-
Induction of the early stages of Friend erythroleukemia with helper-free Friend spleen focus-forming virus.Proc Natl Acad Sci U S A. 1985 Oct;82(20):6913-7. doi: 10.1073/pnas.82.20.6913. Proc Natl Acad Sci U S A. 1985. PMID: 2995992 Free PMC article.
-
Roles of helper and defective retroviral genomes in murine erythroleukemia: studies of spleen focus-forming virus in the absence of helper.J Virol. 1985 Dec;56(3):660-4. doi: 10.1128/JVI.56.3.660-664.1985. J Virol. 1985. PMID: 2999422 Free PMC article.
-
Helper virus is not required for in vitro erythroid transformation of hematopoietic cells by Friend virus.Proc Natl Acad Sci U S A. 1980 Sep;77(9):5287-91. doi: 10.1073/pnas.77.9.5287. Proc Natl Acad Sci U S A. 1980. PMID: 6933561 Free PMC article.
-
Erythroleukaemia induction by the Friend spleen focus-forming virus.Baillieres Clin Haematol. 1995 Mar;8(1):225-47. doi: 10.1016/s0950-3536(05)80239-2. Baillieres Clin Haematol. 1995. PMID: 7663048 Review.
Cited by
-
Vagal-mAChR4 signaling promotes Friend virus complex (FV)-induced acute erythroleukemia.Virol Sin. 2023 Jun;38(3):429-439. doi: 10.1016/j.virs.2023.05.005. Epub 2023 May 10. Virol Sin. 2023. PMID: 37172825 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources